Your browser doesn't support javascript.
loading
Predictive Value of Serial ECGs in Patients with Suspected Myocardial Infarction.
Lehmacher, Jonas; Neumann, Johannes Tobias; Sörensen, Nils Arne; Goßling, Alina; Haller, Paul Michael; Hartikainen, Tau Sarra; Clemmensen, Peter; Zeller, Tanja; Blankenberg, Stefan; Westermann, Dirk.
Afiliação
  • Lehmacher J; Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
  • Neumann JT; Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
  • Sörensen NA; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), 10785 Berlin, Germany.
  • Goßling A; Department of Epidemiology and Preventative Medicine, Monash University, Melbourne VIC 3004, Australia.
  • Haller PM; Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
  • Hartikainen TS; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), 10785 Berlin, Germany.
  • Clemmensen P; Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
  • Zeller T; Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
  • Blankenberg S; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), 10785 Berlin, Germany.
  • Westermann D; Department of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
J Clin Med ; 9(7)2020 Jul 20.
Article em En | MEDLINE | ID: mdl-32698466
ABSTRACT
The electrocardiogram (ECG) is an important diagnostic tool for patients with suspected acute myocardial infarction (AMI). Current guidelines recommend serial ECGs in case of persisting symptoms. We aimed to analyze the predictive value of ischemic ECG-signs in patients with suspected AMI. Patients presenting to the emergency department with suspected AMI were included. All patients with ST-elevation AMI were excluded from analyses. Patients received 12-lead-ECG and high-sensitive Troponin T (hs-TnT)-measurement at admission and after 3 h. Four groups were defined no ischemic signs in either ECG; new ischemic signs in the second ECG; resolved ischemic signs in the second ECG; and persistent ischemic signs in both ECGs. Patients were followed for 2 years to assess the composite endpoint of all-cause-mortality, AMI, and coronary revascularization. Using a 30-day landmark analysis, a Cox regression with ischemic signs as the variable of interest, adjusted by cardiovascular risk factors, was calculated. Of 1675 patients, 1321 showed no ischemic signs, in 25 new-, in 92 resolved- and in 237 patients, persistent ischemic signs were documented. Patients with persistent ischemic signs had significantly worse outcomes, compared to those without. Compared to no ischemic signs, adjusted hazard ratios for the combined endpoint were 0.81 (95% CI 0.20, 3.31; p-value = 0.77) for new-, 0.59 (95% CI 0.26, 1.34; p-value = 0.21) for resolved-, and 1.47 (95% CI 1.102, 2.13; p-value = 0.041) for persistent ischemic signs. In patients with suspected AMI, persistent ischemic ECG-signs are predictive of a higher rate of all-cause-mortality, AMI, and revascularization.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2020 Tipo de documento: Article